Delivery Order SPE2DB20D3101-SPE2DB26FQTP3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $10,520.07 delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes. This is a firm fixed price contract with an ultimate completion date of July 28, 2025, representing a non-set-aside procurement awarded competitively on July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,736.84 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,275.20 firm fixed-price delivery order for Durolane 60 mg/3 ml syringes on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-competitive, non-set-aside award is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $3,187.90 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Durolane 60 mg/3 mL syringes. The contract, which is not set-aside and was competitively awarded, is classified as a firm fixed price delivery order with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on June 27, 2025, for the supply of Durolane 60 mg/3 ml syringes. The contract is valued at $2,501.28 under a firm fixed-price arrangement with an ultimate completion date of June 30, 2025. This delivery order carries no set-aside designation and was competitively awarded. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,523.79 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Durolane 60 mg/3 mL syringes. This non-set-aside, firm fixed-price contract is scheduled for completion by August 12, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements for military and defense healthcare...
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $6,899.84. The award, issued on April 28, 2025, with an ultimate completion date of April 29, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB26FQTP3Delivery Order
The Defense Logistics Agency (DLA) awarded a $3,825.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes, with an ultimate completion date of November 12, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical supply portfolio to the Defense Health Agency and other federal customers. The company's DLA Troop Support Medical IDC enables the supply of a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs globally. The award of this specific delivery order for hyaluronic acid joint injection therapy demonstrates the contractor's capability to fulfill federal procurement requirements through open competition and reflects the company's established position as a key vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/10/25 |